402 related articles for article (PubMed ID: 27277133)
1. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
[TBL] [Abstract][Full Text] [Related]
2. Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies.
Bonamichi-Santos R; Castells M
Curr Pharm Des; 2016; 22(45):6870-6880. PubMed ID: 27784245
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
Galvão VR; Castells MC
J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
[TBL] [Abstract][Full Text] [Related]
4. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.
Labella M; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):623-629. PubMed ID: 33781937
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis to chemotherapy and monoclonal antibodies.
Castells MC
Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
Castells M; Sancho-Serra Mdel C; Simarro M
Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
[TBL] [Abstract][Full Text] [Related]
8. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
Sloane D; Govindarajulu U; Harrow-Mortelliti J; Barry W; Hsu FI; Hong D; Laidlaw T; Palis R; Legere H; Bunyavanich S; Breslow R; Wesemann D; Barrett N; Brennan P; Chong HJ; Liu A; Fernandez J; Fanning L; Kyin T; Cahill K; Bankova L; Lynch A; Berlin S; Campos S; Fuchs C; Mayer R; Matulonis U; Castells M
J Allergy Clin Immunol Pract; 2016; 4(3):497-504. PubMed ID: 26895621
[TBL] [Abstract][Full Text] [Related]
9. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
Castells Guitart MC
J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
[TBL] [Abstract][Full Text] [Related]
10. [Infusion reaction and anaphylaxis].
Yoshida K; Shiono M; Ishioka C
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1753-7. PubMed ID: 22083179
[TBL] [Abstract][Full Text] [Related]
11. Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ
Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
[TBL] [Abstract][Full Text] [Related]
12. Immediate Hypersensitivity Reaction to Chemotherapeutic Agents.
Giavina-Bianchi P; Patil SU; Banerji A
J Allergy Clin Immunol Pract; 2017; 5(3):593-599. PubMed ID: 28483313
[TBL] [Abstract][Full Text] [Related]
13. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
[TBL] [Abstract][Full Text] [Related]
14. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity to antineoplastic agents.
Castells MC
Curr Pharm Des; 2008; 14(27):2892-901. PubMed ID: 18991707
[TBL] [Abstract][Full Text] [Related]
16. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
Picard M; Galvão VR
J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
[TBL] [Abstract][Full Text] [Related]
17. Key elements in hypersensitivity reactions to chemotherapy: experience with rapid drug desensitization in gynaecological cancer in a Tertiary Hospital.
Alen Coutinho I; Costa Sousa F; Cunha F; Frutuoso C; Ribeiro C; Loureiro C; Águas F; Todo Bom A
Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):265-276. PubMed ID: 33944544
[TBL] [Abstract][Full Text] [Related]
18. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
Picard M; Castells MC
Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
[TBL] [Abstract][Full Text] [Related]
19. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity Reactions to Cancer Chemotherapy: Practical Recommendations of ARADyAL for Diagnosis and Desensitization.
Vega A; Jimenez-Rodriguez TW; Barranco R; Bartra J; Diéguez MC; Doña I; Fernández-Rivas M; Gandolfo-Cano M; Gastaminza-Lasarte G; González-Mancebo E; de la Hoz Caballer B; Sánchez-Morillas L; Torres MJ; Berges-Gimeno MP; Muñoz-Cano R
J Investig Allergol Clin Immunol; 2021 Oct; 31(5):364-384. PubMed ID: 34045179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
